KEY PRODUCTS
With Fermion, start the journey of your innovative API.
01 1Fermion Oy
01 1DEXMEDETOMIDINE HYDROCHLORIDE
01 1Finland
01 1Active
01 1Complete
With Fermion, start the journey of your innovative API.
GDUFA
DMF Review : Complete
Rev. Date : 2021-08-31
Pay. Date : 2021-08-26
DMF Number : 13810
Submission : 1998-10-30
Status : Active
Type : II
20
Fermion Oy, based in Finland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for With Fermion, start the journey of your innovative API.
One of their notable products is DEXMEDETOMIDINE HYDROCHLORIDE, with a corresponding US DMF Number 13810.
Remarkably, this DMF maintains an Active status since its submission on October 30, 1998, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 31, 2021, and payment made on August 26, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
